4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[2-carboxy-2-(3-thienyl)acetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt (1:2), (2S,5R,6R)- (2S,5R,6R)-6-[[(2R)-羧基-3-噻吩基乙酰]氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂二环[3.2.0]庚烷-2-羧酸二钠盐

CAS 4697-14-7 MFCD07787410

化学结构图

4697-14-7
SMILES: CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)[O-])c3ccsc3)C(=O)N2[C@@H]1C(=O)[O-].[Na+].[Na+]

化学属性

Mol. FormulaC15
Mol. Weight428
Appearance 乳白色非结晶性粉末,有引湿性。易溶于水(>100g/100m1),得到的澄清溶液的Ph值为6.0~8.0。水溶液相对稳定;酸性溶液相对不稳定。
pH:A

别名和识别编码

Chemical Name4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[2-carboxy-2-(3-thienyl)acetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt (1:2), (2S,5R,6R)-
MDL NumberMFCD00864998
CAS Number4697-14-7
Synonym (2S,5R,6R)-6-[[(2R)-CARBOXY-3-THIENYLACETYL]AMINO]-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID DISODIUM SALT (2S,5R,6R)-6-[[(2R)-Carboxy-3-thienylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid disodium salt (2S,5R,6R)-6-[[(2R)-羧基-3-噻吩基乙酰]氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂二环[3.2.0]庚烷-2-羧酸二钠盐 (2S,5S,6R)-6-[[(2R)-CARBOXY-3-THIENYLACETYL]AMINO]-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3,2,0]HEPT (2s,5r,6r)-6-[[(2r)-carboxy-3-thienylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid disodium salt 3-thiophenemalonamicacid,n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicylo(3 Aerugipen BRL 2288 BRL-2288 BRL2288 CSL Ticillin , Tarcil Disodium, Ticarcillin Neoanabactyl SmithKline Beecham Sodium Ticarcillin
PubChem Substance ID470375
Chemical Name Translation(2S,5R,6R)-6-[[(2R)-羧基-3-噻吩基乙酰]氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂二环[3.2.0]庚烷-2-羧酸二钠盐
Merck Number13,9505
Wiswesser Line NotationT45 ANV ESTJ GVO CMVYVO&- CT5SJ &-NA- 2
InChIKeyZBBCUBMBMZNEME-UBXQQCHXSA-L
LabNetwork Molecule IDLN01312872
InChIInChI=1S/C15H16N2O6S2.2Na/c1-15(2)9(14(22)23)17-11(19)8(12(17)25-15)16-10(18)7(13(20)21)6-3-4-24-5-6;;/h3-5,7-9,12H,1-2H3,(H,16,18)(H,20,21)(H,22,23);;/q;2*+1/p-2/t7-,8-,9+,12-;;/m1../s1
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • {SNA} Antibacterial, Antibiotics, Antibiotics A to Z, Antibiotics T-Z, Antibiotics by Application, Biochemicals and Reagents, Chemical Structure Class, Genetic Marker Selection, Interferes with Cell Wall Synthesis, L - Z, Mechanism of Action, Penicillins and Cephalosporins (beta-Lact
  • {SNA} Antibacterial, Antibiotics, Antibiotics A to Z, Antibiotics T-Z, Antibiotics by Application, Chemical Structure Class, Genetic Marker Selection, Interferes with Cell Wall Synthesis, L - Z, Mechanism of Action, Penicillins and Cephalosporins (beta-Lactams), Spectrum of Activity
  • {SNA} Antibacterial,

安全信息

WGK Germany2
GHS Symbol
Precautionary statements
  • P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
  • P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
  • P271 Use only outdoors or in a well-ventilated area.? 只能在室外或通风良好的地方使用。
  • P272 Contaminated work clothing should not be allowed out of the workplace. 污染的工作服不得带出工作场所。
  • P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
  • P285 In case of inadequate ventilation wear respiratory protection. 在通风不足的情况下,戴呼吸防护。
  • P302+P352
  • P304+P340
  • P304+P341
  • P305+P351+P338
  • P312 Call a POISON CENTER or doctor/physician if you feel unwell. 如果你感觉不适,呼叫解毒中心或医生/医师。
  • P321 Specific treatment (see … on this label). 具体治疗(见本标签上的)。
  • P332+P313
  • P333+P313
  • P337+P313
  • P342+P311
  • P362 Take off contaminated clothing and wash before reuse. 脱掉污染的衣服,清洗后方可重新使用
  • P363 Wash contaminated clothing before reuse. 被污染的衣服洗净后方可重新使用。
  • P403+P233
  • P405 Store locked up. 上锁保管。
  • P501 Dispose of contents/container to..… 处理内容物/容器.....
Hazard statements
  • H315 Causes skin irritation 会刺激皮肤
  • H317 May cause an allergic skin reaction 可能导致皮肤过敏
  • H319 Causes serious eye irritation 严重刺激眼睛
  • H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled 吸入可能导致过敏或哮喘症状或呼吸困难
  • H335 May cause respiratory irritation 可能导致呼吸道刺激
RTECSXM9410000
Signal word Danger
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Hazard Codes Xn Xn,Xi
Safety Statements
  • S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后,立即用大量水冲洗并征求医生意见;
  • S36/37 Wear suitable protective clothing and gloves 穿戴适当的防护服和手套;
Risk Statements
  • R36/37/38 Irritating to eyes, respiratory system and skin 对眼睛、呼吸系统和皮肤有刺激性
  • R43 May cause sensitisation by skin contact 皮肤接触会产生过敏反应
  • R42 May cause sensitisation by inhalation 吸入会产生过敏反应
Storage condition 2-8°C
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 16 gm/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Gastrointestinal - hypermotility, diarrhea
REFERENCE :
   KSRNAM Kiso to Rinsho.  Clinical Report.  (Yubunsha Co., Ltd., 1-5, Kanda
   Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan)  V.1-    1960-
   Volume(issue)/page/year: 12,556,1978

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 7200 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Gastrointestinal - ulceration or bleeding from stomach
   Gastrointestinal - ulceration or bleeding from sma

TYPE OF TEST            :

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 7800 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Gastrointestinal - ulceration or bleeding from small intestine
   Kidney, Ureter, Bladder - other changes
REFERENCE :
   KSRNAM Kiso to Rinsho.  Clinical Report.  (Yubunsha Co., Ltd., 1-5, Kanda
   Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan)  V.1-    1960-
   Volume(issue)/page/year: 12,556,1978

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 10700 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   KSRNAM Kiso to Rinsho.  Clinical Report.  (Yubunsha Co., Ltd., 1-5, Kanda
   Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan)  V.1-    1960-
   Volume(issue)/page/year: 12,556,1978

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 5500 mg/kg
SEX/DURATION            : female 7-17 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
   KSRNAM Kiso to Rinsho.  Clinical Report.  (Yubunsha Co., Ltd., 1-5, Kanda
   Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan)  V.1-    1960-
   Volume(issue)/page/year: 12,556,1978

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 5500 mg/kg
SEX/DURATION            : female 7-17 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
   e.g., stunted fetus)
   Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
   KSRNAM Kiso to Rinsho.  Clinical Report.  (Yubunsha Co., Ltd., 1-5, Kanda
   Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan)  V.1-    1960-
   Volume(issue)/page/year: 12,556,1978

其他信息

  • MOL 文件:4697-14-7.mol
  • Sigma Aldrich:4697-14-7(sigmaaldrich)
  • 方法一:方法l:1.38g(5mm01)(噻吩-3-基)丙二酸单苄酯(I)和2.5ml二氯亚砜,在50~55℃下加热1h,再在60~65℃下加热10min。在减压和低于30℃下,除去过剩的二氯亚砜,最后可以加入1 ml苯,在高真空下利用共沸去除痕量的二氯亚砜,剩下的是黄色油状的(噻吩-3-基)丙二酸单苄酯酰氯(Ⅱ)。把该酰氯(Ⅱ)溶于10ml干燥丙酮,在搅拌和蒸汽浴上,加入1.08g(5mmo1)6-APA、15m11mol/L碳酸氢钠和5ml丙酮的混合溶液。当反应开始进行后将反应液在室温下继续搅拌45min。反应液用乙醚(3×25m1)洗后,再用约11 m11mol/L盐酸酸化至Ph=2,然后用乙醚(3×15m1)萃取该酸性水溶液。萃取液用活性炭和硫酸镁一起脱色5min。过滤,摇晃淡黄色的滤液和约4m11mol/L碳酸氢钠,得到Ph值为7~7.5的水溶性萃取液。该水溶性萃取液在低温低压浓缩后,剩余物加入异丙醇一起搅拌,直到混合物中含10%水为止。此时开始结晶,在0℃下放置过夜使结晶完全。得白色结晶的α - (苄氧羰基)-3-噻吩甲基青霉素钠(Ⅲ),收率50%。 10.65g 5%载于碳酸钙的钯催化剂悬浮于32ml水中,预先氢化1h,然后加入2.13g(4.3mmo1)上面得到的钠盐(Ⅲ)溶于30ml水的溶液,在略高于大气压的压力下氢化1.5h。用装有Dicalite(一种硅藻土)的装置进行过滤。澄清的滤液在低温低压下浓缩,剩余物在五氧化二磷存在下真空干燥,得白色固体的替卡西林钠。 方法2:2-噻吩-2-苄氧羰基乙酰氯(Ⅱ)对6-APA的苄酯进行酰化,得到化合物(Ⅳ),再氢解脱去两个苄基保护基,然后用碳酸氢钠中和即可得到替卡西林钠。
  • 上游原料:氧氯化硫 --> 硅藻土 --> 青霉素钠 --> 酰氯 --> 钯催化剂 --> 苄酯
  • 用途一:半合成青霉素,对绿脓杆菌有高效,临床治疗绿脓杆菌感染有效率为90%左右。对耐药性绿脓杆菌产生的β-内酰胺酶稳定,但易受大肠杆菌、奇异变形杆菌以及个别绿脓杆菌菌株产生的β-内酰胺酶所破坏。和庆大霉素、多粘菌素合用对绿脓杆菌有协同作用。临床用于治疗败血症、泌尿道感染、呼吸道感染和胆道感染,也用于白血病及恶性肿瘤患者的继发感染,对伤寒也有效。替卡西林钠常和克拉维酸配伍制成新抗生素复合剂——泰门汀(Timentin),临床用于治疗严重感染。

系列性分类


相关产品推荐